Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 8

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 8
---
 Preferred Stock, the Series A Warrants and Preferred Warrants, on the terms and conditions set forth in the First Securities Purchase Agreement. “ First PIPE Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of February 14, 2024, by and between CERo and certain PIPE Investors. “ First Securities Purchase Agreement” refers to the Amended and Restated Securities Purchase Agreement, dated as of February 14, 2024, by and among PBAX, Legacy CERo and certain PIPE Investors, pursuant to which CERo agreed to issue and sell 10,039 shares of Series A Preferred Stock, 6,127 Series A Warrants and 2,500 Preferred Warrants. “ Initial Public Offering” refers to the initial public offering of PBAX, which closed on October 8, 2021. “ Investor Rights Agreement” refers to the Investor Rights and Lock-up Agreement, dated February 14, 2024, by and among CERo, the Sponsor, certain Legacy CERo Stockholders and certain other parties. “ Keystone” refers to Keystone Capital Partners, LLC. “ Keystone Commencement Date” refers to the time when all of the conditions to our right to commence sales of Common Stock to Keystone set forth in the respective Keystone Purchase Agreements have been satisfied. “ Keystone Commitment Amount” refers to the $25,000,000 of shares of Common Stock that Keystone has committed to purchase pursuant to the Keystone Purchase Agreements. “ Keystone Commitment Shares” refers to the 19,833 shares of Common Stock that have been issued to Keystone as consideration for Keystone entering into the Keystone Purchase Agreements. “ Keystone Equity Financing” refers to the equity line of credit established by the Keystone Purchase Agreements. “ Keystone Purchase Agreements” refers to the Old Keystone Purchase Agreement and the New Keystone Purchase Agreement. “ Keystone Purchase Shares” refers to the shares of Common Stock that CERo may elect to issue and sell to Keystone after the Keystone Commencement Date. “ Keystone Registration Rights Agreements” refers to the Old Registration Rights Agreement and the New Registration Rights Agreement. “ Legacy CERo” refers to CERo Therapeutics, Inc. “ Legacy CERo common stock” refers to the common stock, par value $0.0001 per share, of Legacy CERo. “ Legacy CERo preferred stock” refers to the preferred stock, par value $0.0001 per share, of Legacy CERo. vi “ Legacy CER